BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harrison S, Benziger H. The molecular biology of colorectal carcinoma and its implications: A review. The Surgeon 2011;9:200-10. [DOI: 10.1016/j.surge.2011.01.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Al Omar SY, Mansour L, Dar JA, Alwasel S, Alkhuriji A, Arafah M, Al Obeed O, Christmas S. The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population. Genet Test Mol Biomarkers 2015;19:617-22. [PMID: 26383988 DOI: 10.1089/gtmb.2015.0105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Wang L, Jiang F, Ma F, Zhang B. MiR-873-5p suppresses cell proliferation and epithelial-mesenchymal transition via directly targeting Jumonji domain-containing protein 8 through the NF-κB pathway in colorectal cancer. J Cell Commun Signal 2019;13:549-60. [PMID: 31152315 DOI: 10.1007/s12079-019-00522-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
3 Tzeng ST, Tsai MH, Chen CL, Lee JX, Jao TM, Yu SL, Yen SJ, Yang YC. NDST4 is a novel candidate tumor suppressor gene at chromosome 4q26 and its genetic loss predicts adverse prognosis in colorectal cancer. PLoS One. 2013;8:e67040. [PMID: 23825612 DOI: 10.1371/journal.pone.0067040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
4 Kim CJ, Tambe Y, Mukaisho K, Sugihara H, Isono T, Sonoda H, Shimizu T, Kondoh G, Inoue H. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice. Carcinogenesis 2014;35:227-36. [PMID: 23975835 DOI: 10.1093/carcin/bgt293] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
5 Coppedè F. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation. Cancer Lett. 2014;342:238-247. [PMID: 22202641 DOI: 10.1016/j.canlet.2011.12.030] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 7.0] [Reference Citation Analysis]
6 矣金华, 刘江, 王昆华. 结直肠癌CpG岛甲基化表型的研究进展. 世界华人消化杂志 2016; 24(4): 558-565 [DOI: 10.11569/wcjd.v24.i4.558] [Reference Citation Analysis]
7 Lino-silva LS, Salcedo-hernández RA, Herrera-gómez A, Padilla-rosciano A, Ramírez-jaramillo M, Herrera-goepfert RE, Meneses-garcía A. Colonic Cribriform Carcinoma, a Morphologic Pattern Associated With Low Survival. Int J Surg Pathol 2015;23:13-9. [DOI: 10.1177/1066896914542125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
8 Coppedè F, Migheli F, Lopomo A, Failli A, Legitimo A, Consolini R, Fontanini G, Sensi E, Servadio A, Seccia M, Zocco G, Chiarugi M, Spisni R, Migliore L. Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens: correlation with physiological and pathological characteristics, and with biomarkers of one-carbon metabolism. Epigenetics 2014;9:621-33. [PMID: 24500500 DOI: 10.4161/epi.27956] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
9 Sperling J, Brandhorst D, Schäfer T, Ziemann C, Benz-Weißer A, Scheuer C, Kollmar O, Schilling MK, Menger MD. Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy. Clin Exp Metastasis 2013;30:447-55. [PMID: 23187934 DOI: 10.1007/s10585-012-9550-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
10 Li G, Xu Y, Wang S, Yan W, Zhao Q, Guo J. MiR-873-5p inhibits cell migration, invasion and epithelial-mesenchymal transition in colorectal cancer via targeting ZEB1. Pathol Res Pract 2019;215:34-9. [PMID: 30455125 DOI: 10.1016/j.prp.2018.10.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
11 Zeng YF, Xiao YS, Lu MZ, Luo XJ, Hu GZ, Deng KY, Wu XM, Xin HB. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma. Exp Mol Pathol. 2015;98:260-267. [PMID: 25758200 DOI: 10.1016/j.yexmp.2015.03.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
12 Yang T, Zhiheng H, Zhanhuai W, Qian X, Yue L, Xiaoxu G, Jingsun W, Shu Z, Kefeng D. Increased RAB31 Expression in Cancer-Associated Fibroblasts Promotes Colon Cancer Progression Through HGF-MET Signaling. Front Oncol 2020;10:1747. [PMID: 33072555 DOI: 10.3389/fonc.2020.01747] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Lai PL, Chen TC, Feng CY, Lin H, Ng CH, Chen Y, Hsiao M, Lu J, Huang HC. Selection of a malignant subpopulation from a colorectal cancer cell line. Oncol Lett 2020;20:2937-45. [PMID: 32782610 DOI: 10.3892/ol.2020.11829] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Johnstone MS, Lynch G, Park J, McSorley S, Edwards J. Novel Methods of Risk Stratifying Patients for Metachronous, Pre-Malignant Colorectal Polyps: A Systematic Review. Crit Rev Oncol Hematol 2021;164:103421. [PMID: 34246774 DOI: 10.1016/j.critrevonc.2021.103421] [Reference Citation Analysis]
15 Yazbeck R, Lindsay R, Abbott CA, Benkendorff K, Howarth GS. Combined Effects of Muricid Extract and 5-Fluorouracil on Intestinal Toxicity in Rats. Evid Based Complement Alternat Med 2015;2015:170858. [PMID: 26074985 DOI: 10.1155/2015/170858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
16 Legitimo A, Consolini R, Failli A, Orsini G, Spisni R. Dendritic cell defects in the colorectal cancer. Hum Vaccin Immunother 2014;10:3224-35. [PMID: 25483675 DOI: 10.4161/hv.29857] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
17 Bajbouj K, Schulze-Luehrmann J, Diermeier S, Amin A, Schneider-Stock R. The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines. BMC Complement Altern Med 2012;12:69. [PMID: 22640402 DOI: 10.1186/1472-6882-12-69] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
18 Liu L, Jia S, Jin X, Zhu S, Zhang S. HOXC11 Expression Is Associated with the Progression of Colon Adenocarcinoma and Is a Prognostic Biomarker. DNA Cell Biol 2021;40:1158-66. [PMID: 34415792 DOI: 10.1089/dna.2021.0368] [Reference Citation Analysis]
19 Zhang Y, Guo L, Li Y, Feng GH, Teng F, Li W, Zhou Q. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer. Mol Cancer 2018;17:1. [PMID: 29304823 DOI: 10.1186/s12943-017-0753-1] [Cited by in Crossref: 106] [Cited by in F6Publishing: 69] [Article Influence: 35.3] [Reference Citation Analysis]
20 Guo Y, Lee JH, Shu L, Huang Y, Li W, Zhang C, Yang AY, Boyanapalli SS, Perekatt A, Hart RP, Verzi M, Kong AN. Association of aberrant DNA methylation in Apc(min/+) mice with the epithelial-mesenchymal transition and Wnt/β-catenin pathways: genome-wide analysis using MeDIP-seq. Cell Biosci 2015;5:24. [PMID: 26101583 DOI: 10.1186/s13578-015-0013-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
21 Ray P, Guha D, Chakraborty J, Banerjee S, Adhikary A, Chakraborty S, Das T, Sa G. Crocetin exploits p53-induced death domain (PIDD) and FAS-associated death domain (FADD) proteins to induce apoptosis in colorectal cancer. Sci Rep 2016;6:32979. [PMID: 27622714 DOI: 10.1038/srep32979] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
22 Sperling J, Schäfer T, Benz-Weißer A, Ziemann C, Scheuer C, Kollmar O, Schilling MK, Menger MD. Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases. Int J Colorectal Dis 2013;28:555-62. [PMID: 23242249 DOI: 10.1007/s00384-012-1617-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
23 Wang ZC, Gao J, Zi SM, Yang M, Du P, Cui L. Aberrant expression of sonic hedgehog pathway in colon cancer and melanosis coli: Hh pathway in colon cancer and MC. Journal of Digestive Diseases 2013;14:417-24. [DOI: 10.1111/1751-2980.12060] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
24 Wakeman C, Keenan J, Eteuati J, Hollington P, Eglinton T, Frizelle F. Chemoprevention of colorectal neoplasia. ANZ J Surg 2017;87:E228-32. [PMID: 26686322 DOI: 10.1111/ans.13392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
25 Wang W, Li D, Xiang L, Lv M, Tao L, Ni T, Deng J, Gu X, Masatara S, Liu Y, Zhou Y. TIMP-2 inhibits metastasis and predicts prognosis of colorectal cancer via regulating MMP-9. Cell Adh Migr 2019;13:273-84. [PMID: 31293204 DOI: 10.1080/19336918.2019.1639303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
26 Wu WC, Hsu CH, Kuan JC, Hsieh JF, Sun CA, Yang T, Wu CC, Chou YC. Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model. Genet Mol Biol. 2013;36:323-328. [PMID: 24130437 DOI: 10.1590/s1415-47572013000300004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
27 Coppedè F, Lopomo A, Spisni R, Migliore L. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer. World J Gastroenterol 2014; 20(4): 943-956 [PMID: 24574767 DOI: 10.3748/wjg.v20.i4.943] [Cited by in CrossRef: 138] [Cited by in F6Publishing: 122] [Article Influence: 19.7] [Reference Citation Analysis]
28 Wu W, Chen J, Ding Q, Yang S, Wang J, Yu H, Lin J. Function of the macrophage-capping protein in colorectal carcinoma. Oncol Lett 2017;14:5549-55. [PMID: 29113183 DOI: 10.3892/ol.2017.6888] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
29 Eisenach PA, Soeth E, Roder C, Kloppel G, Tepel J, Kalthoff H, Sipos B. Dipeptidase 1 (DPEP1) is a marker for the transition from low-grade to high-grade intraepithelial neoplasia and an adverse prognostic factor in colorectal cancer. Br J Cancer. 2013;109:694-703. [PMID: 23839495 DOI: 10.1038/bjc.2013.363] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
30 Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL, Yang YC. Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis. Int J Cancer 2014;135:2593-603. [PMID: 24740680 DOI: 10.1002/ijc.28899] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
31 Cui BH, Hong X. miR-6852 serves as a prognostic biomarker in colorectal cancer and inhibits tumor growth and metastasis by targeting TCF7. Exp Ther Med 2018;16:879-85. [PMID: 30116340 DOI: 10.3892/etm.2018.6259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
32 Castells A. Choosing the optimal method in programmatic colorectal cancer screening: current evidence and controversies. Therap Adv Gastroenterol 2015;8:221-33. [PMID: 26136839 DOI: 10.1177/1756283X15578610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
33 Failli A, Legitimo A, Migheli F, Coppedè F, Mathers JC, Spisni R, Miccoli P, Migliore L, Consolini R. Efficacy and feasibility of the epithelial cell adhesion molecule (EpCAM) immunomagnetic cell sorter for studies of DNA methylation in colorectal cancer. Int J Mol Sci 2013;15:44-57. [PMID: 24362576 DOI: 10.3390/ijms15010044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
34 Ferrández A, Piazuelo E, Castells A. Aspirin and the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol. 2012;26:185-195. [PMID: 22542156 DOI: 10.1016/j.bpg.2012.01.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
35 Papagiorgis PC. Segmental distribution of some common molecular markers for colorectal cancer (CRC): influencing factors and potential implications. Tumour Biol. 2016;37:5727-5734. [PMID: 26842924 DOI: 10.1007/s13277-016-4913-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
36 Dong S, Ding Z, Zhang H, Chen Q. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis. Integr Cancer Ther 2019;18:1534735419864434. [PMID: 31370719 DOI: 10.1177/1534735419864434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Cojocneanu R, Braicu C, Raduly L, Jurj A, Zanoaga O, Magdo L, Irimie A, Muresan MS, Ionescu C, Grigorescu M, Berindan-Neagoe I. Plasma and Tissue Specific miRNA Expression Pattern and Functional Analysis Associated to Colorectal Cancer Patients. Cancers (Basel) 2020;12:E843. [PMID: 32244548 DOI: 10.3390/cancers12040843] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
38 Davudian S, Shajari N, Kazemi T, Mansoori B, Salehi S, Mohammadi A, Shanehbandi D, Shahgoli VK, Asadi M, Baradaran B. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes. Biomedicine & Pharmacotherapy 2016;84:191-8. [DOI: 10.1016/j.biopha.2016.09.021] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
39 Tsai M, Chen W, Yu S, Chen C, Jao T, Huang C, Tzeng S, Yen S, Yang Y. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis. Ann Surg Oncol 2015;22:1481-9. [DOI: 10.1245/s10434-015-4593-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
40 Maletzki C, Stier S, Gruenert U, Gock M, Ostwald C, Prall F, Linnebacher M. Establishment, characterization and chemosensitivity of three mismatch repair deficient cell lines from sporadic and inherited colorectal carcinomas. PLoS One. 2012;7:e52485. [PMID: 23300683 DOI: 10.1371/journal.pone.0052485] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 4.3] [Reference Citation Analysis]